Table 1.
Characteristics | N = 674 (%) | LMRc | P value | |
---|---|---|---|---|
≤1.59 (N = 337) (%) | >1.59 (N = 337) (%) | |||
Sex | ||||
Male | 576 (85.5) | 307 (91.1) | 269 (79.8) | <0.001 |
Female | 98 (14.5) | 30 (8.9) | 68 (20.2) | |
Age | ||||
≤60 years | 310 (46.0) | 146 (43.3) | 164 (48.7) | 0.164 |
>60 years | 364 (54.0) | 191 (56.7) | 173 (51.3) | |
Pathology grade | ||||
Well | 49 (7.4) | 23 (7.0) | 26 (7.8) | 0.304 |
Middle | 446 (67.5) | 231 (70.0) | 215 (65.0) | |
Poorly | 164 (24.8) | 76 (23.0) | 88 (26.6) | |
Undifferentiated | 2 (0.3) | 0 (0) | 2 (0.6) | |
Depth of tumor | ||||
T1a–1b | 64 (9.5) | 29 (8.6) | 35 (10.4) | 0.670 |
T2 | 129 (19.1) | 63 (18.7) | 66 (19.6) | |
T3 | 481 (71.4) | 245 (72.7) | 236 (70.0) | |
Lymph node metastasis | ||||
N0 | 293 (43.5) | 150 (44.5) | 143 (42.4) | 0.142 |
N1 | 212 (31.5) | 101 (30.0) | 111 (32.9) | |
N2 | 117 (17.4) | 53 (15.7) | 64 (19.0) | |
N3 | 52 (7.7) | 33 (9.8) | 19 (5.6) | |
Pathological stage | ||||
1a–1b | 115 (17.1) | 56 (16.6) | 59 (17.5) | 0.949 |
2a–2b | 226 (33.5) | 113 (33.5) | 113 (33.5) | |
3a–3c | 333 (49.4) | 168 (49.9) | 165 (49.0) | |
Vessel invasive | ||||
Yes | 206 (30.6) | 101 (30.0) | 105 (31.2) | 0.738 |
No | 468 (69.4) | 236 (70.0) | 232 (68.8) | |
Nerve infiltration | ||||
Yes | 251 (37.2) | 125 (37.1) | 126 (37.4) | 0.936 |
No | 423 (62.8) | 212 (62.9) | 211 (62.6) | |
Treatment regimen | ||||
S | 457 (67.8) | 224 (66.5) | 233 (69.1) | 0.757 |
S+postoperative C | 155 (23.0) | 81 (24.0) | 74 (22.0) | |
S+postoperative CRT | 62 (9.2) | 32 (9.5) | 30 (8.9) | |
Hospital time | ||||
≤14 days | 560 (83.1) | 265 (78.6) | 295 (87.5) | 0.002 |
>14 days | 114 (16.9) | 72 (21.4) | 42 (12.5) | |
NLRc | ||||
Median | -3.02 (-4.64–-1.69) | -2.26 (-3.93–-0.95) | -3.78 (-5.39–-2.49) | <0.001 |
LMRc | ||||
Median | 1.59 (0.71-2.69) | 0.71 (0.05-1.19) | 2.68 (2.02-3.54) | <0.001 |
PLRc | ||||
Median | -104.89 (-162.16–-54.85) | -100.65 (-159.19–-38.38) | -108.64 (-163.21–-72.47) | 0.003 |